GORE-TEX? VASCULAR GRAFT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-01-18 for GORE-TEX? VASCULAR GRAFT manufactured by W.l. Gore & Associates.

Event Text Entries

[186738033] (b)(6) 2018 was taken as the date of event, because the infection was diagnosed on this date. On (b)(6) 2018 was taken as the best estimate of the date of implant. The phone number of the physician could not be obtained. The investigation involved e-mail communication with the healthcare professional performing the explant evaluation. The explanted device was not returned to gore for evaluation. At present the device is located at an independed laboratory (b)(6). The independed laboratory geprovas provided gore with a preliminary explant evaluation. No analysis of relevant production records in view of supporting the identification of possible causes for the adverse event could be performed, because the lot number of the device remains unknown.
Patient Sequence No: 1, Text Type: N, H10


[186738034] A gore-tex? Vascular graft was implanted in a (b)(6) female patient in (b)(6) 2018 as a femoro-femoral bypass in order to treat a critical ischemia. Reportedly the patient did not have a history of pre-existing infection in the field of treatment. It was reported, that, on (b)(6) 2018, an infection was identified. It was stated, that on (b)(6) 2018, imaging was performed presenting an anastomotic pseudoaneurysm and a possible breach near the anastomosis. Reportedly, on (b)(6) 2018, the gore-tex? Vascular graft was explanted due to the infection and the pseudoaneurysm. It was reported, that the surgeon performed a prostheto-prosthetic bypass to repair the issue locally. It was stated, that the patient received antipyretic and antibiotic treatment. It was reported, that the patient is doing well. In the provided explant report it is stated, that the gore-tex? Vascular graft was separated in two segments. One of this explanted segments revealed a total obstruction of the prosthetic lumen due to the loss of some reinforcement rings allowing the graft to collapse. Moreover, a green multifilament has been used as a ligature. The physician stated, that the infection was neither caused by the gore-tex? Vascular graft nor did the gore-tex? Vascular graft contribute to the infection. The physician also stated, that the infection was neither caused by the procedure to implant the gore-tex? Vascular graft nor did the procedure contribute to the infection.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2017233-2020-00046
MDR Report Key9604734
Date Received2020-01-18
Date of Report2020-03-03
Date of Event2018-10-04
Date Added to Maude2020-01-18
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSIBYLLE STAERK
Manufacturer Street1500 N. 4TH STREET
Manufacturer CityAZ
Manufacturer Phone9285263030
Manufacturer G1MEDICAL WEST B/P
Manufacturer Street1505 N. FOURTH STREET
Manufacturer CityFLAGSTAFF AZ 86004
Manufacturer CountryUS
Manufacturer Postal Code86004
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameGORE-TEX? VASCULAR GRAFT
Generic NamePROSTHESIS, VASCULAR GRAFT
Product CodeDSY
Date Received2020-01-18
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerW.L. GORE & ASSOCIATES
Manufacturer AddressFLAGSTAFF AZ


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization 2020-01-18

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.